ATE190497T1 - Verwendung des rekombinanten koloniestimulierenden faktors-1 - Google Patents

Verwendung des rekombinanten koloniestimulierenden faktors-1

Info

Publication number
ATE190497T1
ATE190497T1 AT91917632T AT91917632T ATE190497T1 AT E190497 T1 ATE190497 T1 AT E190497T1 AT 91917632 T AT91917632 T AT 91917632T AT 91917632 T AT91917632 T AT 91917632T AT E190497 T1 ATE190497 T1 AT E190497T1
Authority
AT
Austria
Prior art keywords
stimulating factor
csf
recombinant colony
recombinant
colony
Prior art date
Application number
AT91917632T
Other languages
English (en)
Inventor
Peter Ralph
Kong T Chong
James Devlin
Robert Zimmerman
Sharon Lea Aukerman
David B Ring
Sylvia Hsieh Ma
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE190497T1 publication Critical patent/ATE190497T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT91917632T 1990-08-23 1991-08-23 Verwendung des rekombinanten koloniestimulierenden faktors-1 ATE190497T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57214990A 1990-08-23 1990-08-23
PCT/US1991/006052 WO1992003151A1 (en) 1990-08-23 1991-08-23 Uses of recombinant colony stimulating factor-1

Publications (1)

Publication Number Publication Date
ATE190497T1 true ATE190497T1 (de) 2000-04-15

Family

ID=24286555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917632T ATE190497T1 (de) 1990-08-23 1991-08-23 Verwendung des rekombinanten koloniestimulierenden faktors-1

Country Status (7)

Country Link
EP (2) EP0955056A1 (de)
JP (3) JP3501801B2 (de)
KR (1) KR100234870B1 (de)
AT (1) ATE190497T1 (de)
AU (1) AU646299B2 (de)
DE (1) DE69132051D1 (de)
WO (1) WO1992003151A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063372A (en) * 1995-10-27 2000-05-16 Inserm, Institut National De La Sante Et De La Recherche Medicale Uses of mammalian CTLA-8 and related reagents
DK0862454T3 (da) * 1995-10-27 2002-12-30 Schering Corp CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
RU2175554C2 (ru) * 1999-03-30 2001-11-10 Пермское научно-производственное объединение "Биомед" Оральный препарат интерферона в виде таблеток
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
CN101134119A (zh) 2002-05-24 2008-03-05 血管技术国际股份公司 用于涂覆医用植入物的组合物和方法
EP1706137A2 (de) * 2004-01-21 2006-10-04 Chiron Corporation M-csf-muteine und deren verwendung
GB0900786D0 (en) * 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
EP2511366A4 (de) * 2009-12-09 2014-04-30 Univ Kyoto Mittel mit nitrovin zur förderung der differenzierung pluripotenter stammzellen in herzmuskelzellen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121944T1 (de) * 1987-09-22 1995-05-15 Cetus Oncology Corp Verwendungen von rekombinantem koloniestimulierendem faktor-1.

Also Published As

Publication number Publication date
EP0955056A1 (de) 1999-11-10
JP3501801B2 (ja) 2004-03-02
DE69132051D1 (de) 2000-04-20
WO1992003151A1 (en) 1992-03-05
JPH06500558A (ja) 1994-01-20
KR930701186A (ko) 1993-06-11
JP2003292454A (ja) 2003-10-15
KR100234870B1 (ko) 1999-12-15
AU8647491A (en) 1992-03-17
EP0549702B1 (de) 2000-03-15
EP0549702A1 (de) 1993-07-07
JP2002275089A (ja) 2002-09-25
AU646299B2 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
NO882772L (no) Nye former koloni-stimulerende faktor-1.
RU2008146718A (ru) Способы лечения неврологических состояний с применением гематопоэтических факторов роста
DK0741576T3 (da) Sam-administrering af interleukin-3 mutanter med kolonistimulerende faktorer
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
DK174690D0 (da) Antibakterielle midler
DK0790255T3 (da) Monoklonale antistoffer som er rettet mod den cytotoksiske lymfocytmodningsfaktor
DK0402068T3 (da) Polypeptider og polypeptidanaloger med inhiberende virkning mod human elastase
DE3856588D1 (de) Biologisch-aktive Bakterizide/permeabilitätserhöhende Proteinbruchstücke
ATE124959T1 (de) Herstellung und verwendung von nicht- glycosiliertem il-6.
DOP1981004064A (es) Interferones leucocitarios hibridos para uso en el tratamiento de enfermedades neoplasticas virales.
DE69132051D1 (de) Verwendung des rekombinanten koloniestimulierenden faktors-1
DK471386D0 (da) Farmaceutisk komposition til behandling af leukopeni
DE69206301D1 (de) Protein mit der Aktivität vom Typ von Cytokin, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
NO177863C (no) Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer
DE60228136D1 (de) Cytokin-proteinfamilie
ATE213950T1 (de) Verwendung von rekombinantem koloniestimulierendem faktor-1 zur herstellung eines medikaments gegen cytomegalovirusinfektionen
DK12990D0 (da) Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
CA2090121A1 (en) Uses of colony stimulating factor-1
DK103891A (da) Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
DE69318567D1 (de) Kalzium-kanal-blockierende polypeptide aus theraphosidae aphonopelma